The Discounted Cash Flow (DCF) valuation of Catalyst Pharmaceuticals Inc (CPRX) is 38.90 USD. With the latest stock price at 19.64 USD, the upside of Catalyst Pharmaceuticals Inc based on DCF is 98.1%.
Based on the latest price of 19.64 USD and our DCF valuation, Catalyst Pharmaceuticals Inc (CPRX) is a buy. buying CPRX stocks now will result in a potential gain of 98.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.0% | 6.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 28.26 - 71.02 | 38.90 |
| Upside | 43.9% - 261.7% | 98.1% |